Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
DXCM

Market Cap: $31.33B

DI

DexCom, Inc.

DXCM

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

DexCom (DXCM) Financials & Key Data

Financials

Profitability

Gross Profit Margin62.47%

EBITDA Margin31.38%

EBIT Margin26.06%

Pre-tax Margin25.76%

Net Profit Margin20.12%

Earnings Yield3.14%

Valuation Multiples

Price / Book12.15

Price / Sales6.31

Price / Earnings32.06

PEG0.42

Forward PEG1.89

EV / Sales6.36

Cash Flow & Capital

Free Cash Flow / Share$3.66

Operating Cash Flow / Share$4.56

Free Cash Flow Yield4.48%

Capex / Revenue6.92%

Capex / Operating Cash Flow19.65%

Capex / Depreciation1.30

Liquidity & Leverage

Current Ratio1.73

Quick Ratio1.43

Cash Ratio0.47

Debt / Assets0.22

Debt / Capital0.35

Debt / Equity0.53

Efficiency & Working Capital

Asset Turnover0.77

Fixed Asset Turnover2.98

Inventory Turnover2.57

Receivables Turnover3.87

Payables Turnover4.40

Days Sales Outstanding94.25

Returns & Quality

Return on Equity36.19%

Return on Assets15.49%

Return on Invested Capital21.60%

ROCE27.80%

Return on Tangible Assets15.79%

Operating Return on Assets17.41%

Balance Sheet & Intrinsic Metrics

Enterprise Value$31.63B

Invested Capital$3.52B

Working Capital$1.73B

Tangible Asset Value$2.5B

Net Current Asset Value$252.7M

Graham Number

Financial Health Scores

Piotroski Score8

Altman Z-Score7.34

Revenue$4.97B

EBIT$1.3B

Market Cap$31.7B

Working Capital$1.73B

EV / EBITDA

20.28

EV / Operating Cash Flow18.09

EV / Free Cash Flow22.51

Price / Free Cash Flow22.30

Price / Operating Cash Flow18.22

Stock Compensation / Revenue3.27%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Long-Term Debt / Capital

0.32

Debt / Market Cap3.97%

Net Debt / EBITDA0.19

Solvency Ratio0.33

Financial Leverage2.46

Days Inventory Outstanding142.18

Days Payables Outstanding82.95

Operating Cycle236.43

Cash Conversion Cycle153.48

Working Capital Turnover2.59

Income Quality1.75

Tax Burden0.78

Interest Burden0.99

$20.01

Graham Net-Net-$1.46

Book Value / Share$6.83

Tangible Book Value / Share$6.5

Cash / Share$5.07

Retained Earnings

$2.88B

Total Assets$6.46B

Total Liabilities$3.83B